Summary:
Local doctors are recruiting participants to enroll in a two-period clinical research study on an investigational drug for subjects with active moderate to severe psoriatic arthritis and have inadequate response to non-biologic disease modifying anti-rheumatic drugs (DMARDs).
Qualified Participants Must:
• Be 18 years old or older
•
Have been diagnosed with Psoriatic Arthritis (PsA) with symptoms for at least 6 months
•
Have been diagnosed with active plaque psoriasis or documented history of plaque psoriasis
•
Have inadequate response to previous or current treatment with at least 1 non-biologic DMARD at maximally tolerated dose (MTX, SSZ, LEF, cyclosporine, apremilast, bucillamine, or iguratimod)
Qualified Participants May Receive:
Study-related medication and study-related care is provided at no cost to qualified participants. Qualified participants may be compensation for travel.